LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 70.08 | 27.76 | 1 | 6849 | 0.0001 | -0.3418 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 70.08 | 27.76 | 1 | 6849 | 0.0001 | -0.3418 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.78 | 27.76 | 1 | 6893 | 0.0001 | -0.3415 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.78 | 27.76 | 113 | 6893 | 0.0164 | 0.1930 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.78 | 27.76 | 1 | 6893 | 0.0001 | -0.3415 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.78 | 27.76 | 1 | 6893 | 0.0001 | -0.3415 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.48 | 27.76 | 1 | 6957 | 0.0001 | -0.3410 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.48 | 27.76 | 69 | 6957 | 0.0099 | 0.1210 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.48 | 27.76 | 1 | 6957 | 0.0001 | -0.3410 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 73.48 | 27.76 | 1 | 6957 | 0.0001 | -0.3410 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.19 | 27.76 | 1 | 7015 | 0.0001 | -0.3406 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.19 | 27.76 | 48 | 7015 | 0.0068 | 0.0710 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.19 | 27.76 | 1 | 7015 | 0.0001 | -0.3406 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.19 | 27.76 | 1 | 7015 | 0.0001 | -0.3406 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.89 | 27.76 | 1 | 7025 | 0.0001 | -0.3405 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.89 | 27.76 | 18 | 7025 | 0.0026 | -0.0528 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.89 | 27.76 | 1 | 7025 | 0.0001 | -0.3405 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 76.89 | 27.76 | 1 | 7025 | 0.0001 | -0.3405 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.60 | 27.76 | 1 | 7045 | 0.0001 | -0.3404 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.60 | 27.76 | 16 | 7045 | 0.0023 | -0.0667 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.60 | 27.76 | 1 | 7045 | 0.0001 | -0.3404 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 78.60 | 27.76 | 1 | 7045 | 0.0001 | -0.3404 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.31 | 27.76 | 1 | 6976 | 0.0001 | -0.3409 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.31 | 27.76 | 5 | 6976 | 0.0007 | -0.1934 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.31 | 27.76 | 1 | 6976 | 0.0001 | -0.3409 | MN20160318_Q01 | L09 |